MG1-MAGEA3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MG1-MAGEA3, covering 2020-10-06 to 2020-10-06. Get the full timeline:
Most recent: Clinical Trial Update: Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients [Phase 1, Phase 2]